Aldevron, L.L.C.

United States of America


 
Total IP 87
Total IP Rank # 15,429
IP Activity Score 2.7/5.0    70
IP Activity Rank # 10,185
Dominant Nice Class Chemical and biological material...

Patents

Trademarks

42 13
11 5
9 0
7
 
Last Patent 2025 - Cell-free method of producing sy...
First Patent 2005 - E. coli for plasmid dna production
Last Trademark 2025 - ALCHEMY
First Trademark 2011 - ALDEVRON

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 Invention Cell-free method of producing synthetic circular nucleic acid. The present disclosure relates to...
G/S Reagents for use in genetic research; Reagents for scientific or medical research use; Biochemica...
2024 Invention Gene therapy vectors and methods of production and use thereof. Provided herein are improved DNA ...
Invention Synthetic dna vectors and methods of use. Provided herein are isolated DNA vectors comprising a ...
Invention Quantification of free guide rna in crispr complexes. The present invention relates to a novel an...
Invention Gene therapies for the front of the eye. The present invention involves therapies for ocular dise...
2023 Invention Replicative minicircle vectors with improved expression. A eukaryotic replicative pUC-free minic...
Invention Devices and methods for electrotransfer. Provided herein are electrotransfer devices for deliver...
Invention Chromatography column stand. A chromatography column stand includes a floor portion, a wall porti...
Invention Best1 vectors and uses thereof. Provided herein are expression constructs, nucleic acid vectors, ...
Invention Cell-free method of producing synthetic circular nucleic acid
Invention Cell-free method of producing synthetic circular nucleic acid. The present disclosure relates to ...
Invention Methods for producing cyclic dinucleotides. The present disclosure provides a method of producing...
Invention Muscle-specific hybrid promoter. The present disclosure provides novel combinations of muscle-sp...
2022 Invention Devices and methods for hollow tissue electrotransfer. The invention provides devices and system...
Invention Production of gene therapy vector in engineered bacteria. Provided herein are improved methods o...
Invention Dna plasmids with improved expression. The present invention relates to the production and use o...
Invention Synthetic dna vectors and methods of use. Provided herein are isolated DNA vectors comprising a h...
Invention Respiratory delivery of therapeutic agents. Provided herein are methods of delivering therapeuti...
Invention Respiratory delivery of therapeutic agents. Provided herein are methods of delivering therapeutic...
Invention Synthetic production of circular dna vectors. Provided herein are improved methods of producing ...
Invention Synthetic production of circular dna vectors. Provided herein are improved methods of producing t...
G/S Biological substances, namely, microorganisms engineered for plasmid DNA manufacturing.
G/S Biological substances, materials, and preparations for manufacture and development of gene therap...
G/S Biological substances, namely, cellular growth media for use in plasmid DNA manufacturing platfor...
G/S Plasmid DNA manufacturing platform; biological processes for plasmid DNA manufacturing using biol...
G/S Biological substances, namely, microorganisms engineered for plasmid DNA manufacturing
Invention Bacterial host strains. The present disclosure provides engineered E. coli host cells that combi...
G/S Enzymes in the nature of nucleases and nuclease panels for scientific and research purposes; enzy...
G/S DNA-modifying endonucleases and nucleic acid vectors for scientific and research purposes, namely...
Invention Ocular delivery of therapeutic agents. The present invention involves devices and therapies for ...
Invention Ocular delivery of therapeutic agents. The present invention involves devices and therapies for o...
Invention Nucleic acid vectors and methods of use. The present invention involves nucleic acid vectors (e....
G/S Biological preparations for use in industry and science, namely, for manufacture and development ...
G/S Biological preparations for use in industry and science, namely culture medium for plasmid DNA ma...
G/S Biological preparations for industry and science, namely, microorganisms engineered for plasmid D...
G/S nucleases and nuclease panels for scientific and research purposes; nucleases and nuclease panels...
G/S Enzymes in the nature of nucleases and nuclease panels for scientific and research purposes; Enzy...
2021 G/S Biochemicals, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodi...
Invention Potent and selective inhibitors of nav1.7. The present disclosure relates to a peptide and its a...
Invention Potent and selective inhibitors of nav1.7. The present disclosure relates to a peptide and its an...
Invention Muscle-specific hybrid promoter. The present disclosure provides novel combinations of muscle-spe...
Invention Bacterial host strains. The present disclosure provides engineered E. coli host cells that combin...
Invention Growth of bacterial host cells in gas permeable low-density polyethylene bags for production of p...
2020 Invention Dna plasmids with improved expression. The present invention relates to the production and use of...
Invention Replicative minicircle vectors with improved expression. A eukaryotic replicative pUC-free minici...
Invention Viral and non-viral nanoplasmid vectors with improved production. A method for improving the rep...
Invention Growing bacterial host cells in gas-permeable low-density polyethylene bags to produce plasmid dn...
2019 Invention Viral and non-viral nanoplasmid vectors with improved production. A method for improving the repl...
2018 Invention Replicative minicircle vectors with improved expression. The present invention relates to the pro...
2017 G/S Manufacturing services for others in the field of biologics for research, clinical and diagnostic...
G/S Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ...
G/S Biologics, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodies ...
2016 G/S Manufacturing services for others in the field of biologics for research, clinical, and diagnosti...
2015 Invention Vectors and methods for genetic immunization. Improved DNA vaccine plasmids are disclosed that co...
Invention E. coli plasmid dna production. General methods and strains of bacteria are described that dramat...
2011 G/S Contract manufacturing in the field of biologics for research, clinical, and diagnostic applicati...